We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FDS:NYSEFactSet Research Systems Inc. Analysis

Data as of 2026-04-02 - not real-time

$227.68

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

FactSet is trading below its 200‑day SMA, indicating a short‑term bearish bias, yet the RSI in the low‑60s shows momentum remains on the upside side. The MACD histogram is positive and the signal line turned bullish, suggesting a possible technical rebound. Valuation metrics are attractive: the current price sits well under the DCF‑derived fair value and the PE of ~14.5x is below the industry average of ~16.6x. Revenue is growing at roughly 7% YoY with robust gross and operating margins, and the company generates solid free cash flow to support its 27% payout ratio. Dividend yield near 2% adds income appeal, while the balance sheet shows manageable leverage with a debt‑to‑equity around 73% and ample cash. However, the stock has experienced a 30‑day volatility of over 40% and a historic max drawdown near 60%, underscoring heightened price swings.
Given the upside potential of roughly 11% versus the fair‑value estimate, the blend of growth and value characteristics makes FactSet a compelling buy for investors with a medium to long horizon. The increasing volume trend supports the technical case for a bounce, while the low beta (≈0.6) tempers market‑wide risk. Dividend sustainability appears sound, and the company’s global client base reduces geographic concentration risk. Overall, the fundamentals, dividend profile, and valuation suggest a favorable outlook despite near‑term price pressure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages
  • Positive MACD histogram indicating potential bounce
  • High short‑term volatility and bearish SMA alignment

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value suggests ~11% upside
  • Strong cash flow and sustainable dividend
  • Revenue growth with solid margins

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust ROE and consistent profitability
  • Diversified global client base reducing concentration risk
  • Undervalued relative to peers with attractive dividend yield

Key Metrics & Analysis

Financial Health

Revenue Growth7.10%
Profit Margin24.48%
P/E Ratio14.5
ROE28.08%
ROA11.06%
Debt/Equity72.97
P/B Ratio3.9
Op. Cash Flow$798.9M
Free Cash Flow$596.3M
Industry P/E16.6

Technical Analysis

TrendBearish
RSI62.3
Support$191.23
Resistance$231.21
MA 20$209.23
MA 50$218.39
MA 200$305.08
MACDBullish
VolumeIncreasing
Fear & Greed Index78.8

Valuation

Fair Value$256.79
Target Price$252.69
Upside/Downside10.98%
GradeUndervalued
TypeBlend
Dividend Yield1.96%

Risk Assessment

Beta0.62
Volatility40.94%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.